cfMSC therapy for diabetes for insulin resistance

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Mar 2026: Trial registered, NCT07495956

The trials

NCT07495956: cfMSC Therapy for Diabetes

State
Not started
Phase
Phase 1 and Phase 2
People
30 planned
Started
30 Jun 2027
Primary completion
30 Jun 2029
Arms
Clonal fetal mesenchymal stem cells (cfMSCs) therapy for type II diabetes mellitus
Results
None posted
  1. 27 Mar 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.